Background pattern

Nitoman 25 mg comprimidos

About the medicine

How to use Nitoman 25 mg comprimidos

Introduction

Prospect: information for the user

NITOMAN 25 mg tablets

Tetrabenazine

Read this prospect carefully before starting to take the medication.

  • Keep this prospect, as you may need to read it again.
  • If you have any doubts, consult your doctor or pharmacist.
  • This medication has been prescribed to you and should not be given to others even if they have the same symptoms, as it may harm them.
  • If you consider that any of the adverse effects you are experiencing are severe or if you notice any adverse effect not mentioned in this prospect, inform your doctor.

1. What Nitoman is and for what it is used

2. Before taking Nitoman

3. How to take Nitoman

4. Possible adverse effects

5. Conservation of Nitoman

6. Additional information

1. What is NITOMAN and what is it used for

NITOMAN belongs to a group of medications that act on the nervous system.

This medicationis indicated for the treatment of movement disorders associated with Huntington's chorea (an inherited disorder in which neurons in the brain degenerate and signs of dementia and abnormal movements appear).

2. BEFORE TAKING NITOMAN

No use Nitoman

- If you are allergic (hypersensitive) to tetrabenazine or any of the components of Nitoman.

- During pregnancy and lactation.

- If you have ever been diagnosed with depression or if you have thought or attempted to commit suicide.

  • If you have ever had depression.
  • If you have liver insufficiency (Child-Pugh scale between 5 and 9).
  • If you are taking any medication that contains reserpine.
  • If you have uncontrolled or inadequately treated depression.
  • Tetrabenazine should not be administered in the two weeks following treatment with monoamine oxidase inhibitors (MAOIs) (see sections “Take special care with Nitoman”, “Use of other medications” and “Possible side effects”)
  • If you are taking any medication that contains levodopa or dopaminergic medications (used for the treatment of Parkinson's disease).
  • If you have parkinsonism and rigid-hypokinetic syndrome (parkinsonism).

- In children.

Take special care with Nitoman

- If you are a slow or intermediate metabolizer of an enzyme called CYP2D6, as you may need to receive a different dose.

- If you have Parkinson's disease, as Nitoman may cause parkinsonism and increase existing symptoms of the disease.

-If you are being treated with antidepressants, or have a history of depression, as Nitoman may cause depression or worsen existing depression. Cases of suicidal thoughts and behaviors have been reported in patients taking Nitoman. Consult your doctor before taking this medication. Aggressive and irritable behaviors may occur, or existing ones may worsen.

-If you have liver insufficiency (See section“How to take Nitoman”).

-If you have kidney insufficiency (See section“How to take Nitoman”)

-If you have any heart disease (patients with congenital long QT syndrome, congestive heart failure, hypertrophic cardiomyopathy).

If you have hypotension (low blood pressure).

  • If you have low levels of potassium (hypokalemia) or magnesium (hypomagnesemia).

-When discontinuing treatment, as a malignant neuroleptic syndrome (MNS) may occur (muscle rigidity, fever, and altered consciousness). This syndrome may occur immediately after starting treatment, after increasing the dose, or during prolonged treatment.

Nitoman may elevate serum prolactin levels (hyperprolactinemia). The clinical significance of this is unknown

Use of other medications

Inform your doctor or pharmacist if you are using or have recently used any other medication, including those purchased without a prescription.

The following medications may interact with Nitoman. Inform your doctor if you are taking any of them:

  • Levodopa and dopamine agonists (medications used in the treatment of Parkinson's disease)
  • Reserpine (medication used to treat hypertension) (See section“Do not use Nitoman”).
  • Monoamine oxidase inhibitors (MAOIs) (medications used in the treatment of depression). After discontinuing treatment with MAOIs, it is recommended to wait two weeks before starting treatment with Nitoman. MAOIs should not be used until at least two weeks after the last dose of tetrabenazine, to avoid potentially serious interactions between medications.
  • Medications that increase the effects of the central nervous system (CNS) by increasing the sedative effects of tetrabenazine (neuroleptics, hypnotics, and opioids).
  • Medications used in the treatment of epilepsy (such as phenytoin).
  • Medications that increase the QTc interval (such as tricyclic antidepressants, chlorpromazine, thioridazine), antibiotics (such as gatifloxacin, moxifloxacin), and class I and II antiarrhythmic medications (such as quinidine, procainamide, amiodarone, sotalol). Antipsychotic medications (such as haloperidol, chlorpromazine, thioridazine).
  • Antihypertensive and beta-blockers, may increase the risk of orthostatic hypotension (low blood pressure when standing up).

Use of Nitoman with food and beverages

No interactions with food are known.

This medication may potentiate the effects of alcohol.

Pregnancy and lactation.

Consult your doctor or pharmacist before using any medication.

You should inform your doctor if you are pregnant, or if you think or attempt to become pregnant. Do not take Nitoman during pregnancy.

Do not breastfeed while taking this medication.

Driving and operating machinery

Do not drive or operate tools or machines as Nitoman may cause drowsiness and therefore affect your ability to perform specific tasks.

Important information about some of the components of Nitoman

This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to TAKE NITOMAN

Follow exactly the administration instructions for Nitoman indicated by your doctor. Consult your doctor or pharmacist if you have any doubts.

Remember to take your medication.

Your doctor will indicate the duration of your treatment with Nitoman.

- Adults:

The usual initial dose in adults is one tablet three times a day (a total of 75 mg). This dose is usually increased by one tablet every three or four days, up to a maximum of eight tablets a day (a total of 200 mg).

- Elderly patients:

Your doctor should decide on the appropriate dose.

- Patients with renal insufficiency:

A gradual increase in the dose of this medication is recommended. Additionally, a lower daily dose may be necessary.

- Patients with hepatic insufficiency:

A gradual increase in the dose of this medication is recommended. Additionally, a lower daily dose may be necessary.

- Children:

The use of Nitoman in children is not recommended.

Tablets should be swallowed with a sufficient amount of liquid, either water or another non-alcoholic beverage.

If you take more Nitoman than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately, go to the nearest hospital, or call the Toxicological Information Service. Phone 915 620420.

In case of overdose, the following symptoms may appear: acute dystonia (involuntary muscle contractions affecting the eyes, head, neck, and body), ocular crisis (eyes have an uncontrolled circular movement), excessive blinking, nausea, vomiting, diarrhea, sweating, drowsiness, dizziness, hypotension (decreased blood pressure), hypothermia (decreased body temperature), confusion, hallucination, sedation, redness/inflammation, and tremor.

If you forget to take Nitoman

Do not take a double dose to compensate for the missed doses. Continue taking your regular dose when it is due.

If you interrupt treatment with Nitoman

It is recommended to discontinue treatment gradually. Sudden interruption of treatment could induce a malignant neuroleptic syndrome (a serious condition characterized by muscle rigidity, high fever, and somnolence).

4. Possible Adverse Effects

Like all medicines, Nitoman may cause side effects, although not everyone will experience them.

The side effects are generally mild and reversible upon discontinuing treatment.

The following adverse reactions are presented according to the MedDRA classification and by frequency:

Very common(may affect more than 1 in 10 people)

  • Depression (feeling of sadness), which has been reported to be associated with suicidal thoughts and behaviors. If you feel down or very sad or may be starting to become depressed, inform your doctor about this change.
  • Parkinsonism (may include symptoms such as muscle rigidity, tremors, and balance or gait problems).
  • Common(may affect up to 1 in 10 people)Agitation
  • Anxiety (restlessness)
  • Confusion

Very rare(may affect up to 1 in 10,000 people)

  • Suicidal thoughts
  • If you have intentionally attempted to harm yourself or have started thinking about harming yourself.
  • Irritability or aggressive behavior
  • Malignant neuroleptic syndrome (muscle rigidity, fever, and altered consciousness)
  • Pneumonia
  • Ocular-gyric crisis (eyes have an uncontrolled circular movement)

Frequency not known(cannot be estimated from available data)

  • Dizziness and postural hypotension (dizziness or even fainting that occurs when standing up quickly from a seated position)
  • Bradycardia (decreased heart rate)
  • Acatisia (sensation of bodily unease without reaching anxiety)
  • Hypertensive crisis (critical increase in blood pressure)

Other known adverse effects are:

Very common(may affect more than 1 in 10 people)

  • Drowsiness
  • Tremors
  • Excessive salivation

Common(may affect up to 1 in 10 people)

  • Insomnia (difficulty sleeping)

Very rare(may affect up to 1 in 10,000 people)

  • Leucopenia (decreased number of white blood cells)
  • Decreased appetite, dehydration (lack of water in the body), weight loss
  • Photophobia (intolerance to light)
  • Rash, pruritus, or urticaria
  • Falls

Frequency not known(cannot be estimated from available data)

  • Disorientation, nervousness, discomfort, sleep disturbances
  • Ataxia (uncoordinated movements), dystonia (involuntary muscle contractions)
  • Memory loss
  • Difficulty swallowing, nausea, vomiting, abdominal pain, diarrhea, constipation, dry mouth
  • Increased appetite, weight gain
  • Excessive sweating (hyperhidrosis)
  • Irregular menstrual cycle
  • Fatigue, weakness, hypothermia (reduced body temperature)

Reporting of adverse effects:

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es.

By reporting adverse effects, you can contribute to providing more information about the safety of this medication.

5. Conservation of NITOMAN

Keep out of reach and sight of children.

Do not store at a temperature above 86°F (30°C).

Do not use Nitoman after the expiration date that appears on the packaging after CAD.

The expiration date is the last day of the month indicated.

Medicines should not be disposed of through drains or in the trash. Dispose of packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of unused packaging and medicines.In this way, you will help protect the environment.

6. ADDITIONAL INFORMATION

Composition of Nitoman 25 mg tablets

The active ingredient is tetrabenazine.

The other components are: lactose monohydrate, cornstarch, talc, magnesium stearate, and yellow iron oxide (E172).

Appearance of the product and contents of the package

Beige-yellow, cylindrical, biplanar, beveled-edge, scored tablets with the mark “CL25”.

Child-resistant bottle and cap made of high-density white polyethylene, containing 112 tablets.

Holder of the marketing authorization and responsible for manufacturing

Holder:

Bausch Health Ireland Limited

3013 Lake Drive

Citywest Business Campus

Dublin 24, D24PPT3, Ireland.

Responsible for manufacturing:

Astrea Fontaine

Rue des Pres Potes – 21121

Fontaine Les Dijon - (France)

For more information about this medication, please contact the local representative of the marketing authorization holder:

Zentiva Spain S.L.U.

Paseo Club Deportivo 1, Edif 4.

Pozuelo de Alarcón 28223 – Madrid, Spain

Detailed and updated information about this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/

This leaflet was approved in August 2022

About the medicine

How much does Nitoman 25 mg comprimidos cost in Spain in 2025?

The average price of Nitoman 25 mg comprimidos in July, 2025 is around 123.54 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Talk to a doctor online

Have questions about this medication or your symptoms? Connect with a licensed doctor for guidance and personalized care.

5.07 reviews
Doctor

Anna Moret

Dermatology18 years of experience

Dr. Anna Moret is a board-certified dermatologist and dermatovenereologist. She specialises in adult and pediatric dermatology, venereology, aesthetic skin care, and general medicine. Her consultations are evidence-based and tailored to each patient’s dermatological needs.

Dr. Moret provides expert evaluation and treatment for: • Skin conditions such as eczema, acne, rosacea, dermatitis, and psoriasis • Hair and scalp issues including hair loss, dandruff, and seborrheic dermatitis • Pediatric skin problems — from newborns to adolescents • Sexually transmitted infections (STIs) and dermatovenereology • Aesthetic concerns: skin ageing, non-invasive cosmetic treatments • Skin allergies and hypersensitivity reactions • Mole checks, lesion evaluation, and skin cancer screening • Skincare advice and personalised cosmeceutical routines

Combining dermatology with general medical knowledge, Dr. Moret offers comprehensive care that addresses both skin health and underlying conditions. She also holds certification from the Canadian Board of Aesthetic Medicine, ensuring an internationally aligned approach to aesthetic dermatology.

CameraBook a video appointment
5.043 reviews
Doctor

Alina Tsurkan

Family medicine12 years of experience

Dr. Alina Tsurkan is a licensed family medicine physician based in Portugal, offering online consultations for adults and children. She provides professional primary care, with a focus on prevention, accurate diagnosis, and long-term management of acute and chronic conditions.

Dr. Tsurkan supports patients with a wide range of health issues, including: • Respiratory infections: cold, flu, bronchitis, pneumonia, and lingering coughs • ENT conditions: sinusitis, tonsillitis, otitis (ear infections), sore throat, allergic rhinitis • Eye conditions: allergic or infectious conjunctivitis, red eyes, irritation • Digestive issues: acid reflux (GERD), gastritis, irritable bowel syndrome (IBS), constipation, bloating, nausea • Urinary and reproductive health: urinary tract infections (UTIs), cystitis, prevention of recurrent infections • Chronic diseases: hypertension, diabetes, thyroid disorders, elevated cholesterol, weight management • Neurological complaints: headaches, migraines, sleep disturbances, fatigue, general weakness • Women’s health: menstrual irregularities, perimenopausal symptoms, preventive screening • Children’s health: fever, infections, digestive issues, follow-ups, vaccination guidance

She also provides: • IMT medical certificates for driving licence exchange in Portugal • Personalised preventive care and wellness consultations • Interpretation of test results and medical reports • Follow-up care and medication review • Support in managing multiple coexisting conditions • Remote prescription management and medical documentation

Dr. Tsurkan’s approach is evidence-based and holistic. She works closely with each patient to develop an individualised care plan that addresses both symptoms and root causes. Her goal is to empower patients to take control of their health and maintain well-being through lifestyle adjustments, routine check-ups, and early intervention.

CameraBook a video appointment
5.078 reviews
Doctor

Andrei Popov

General medicine6 years of experience

Dr. Andrei Popov is a licensed pain management specialist and general practitioner based in Spain. He provides expert online care for adults dealing with both chronic and acute pain, as well as a wide range of everyday health concerns.

He specialises in diagnosing and treating pain conditions that affect quality of life, including: • Chronic pain lasting more than 3 months • Migraines and recurring headaches • Neck, back, lower back, and joint pain • Post-traumatic pain following injury or surgery • Nerve-related pain, fibromyalgia, and neuralgia In addition to pain management, Dr. Popov helps patients with: • Respiratory infections (colds, bronchitis, pneumonia) • High blood pressure and metabolic conditions such as diabetes • Preventive care and routine health check-ups

Online consultations last up to 30 minutes and include a detailed symptom review, personalised treatment planning, and medical follow-up when needed.

Dr. Popov’s approach is rooted in evidence-based medicine, combined with individualised care tailored to each patient’s history, lifestyle, and clinical needs.

CameraBook a video appointment
5.017 reviews
Doctor

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise: • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan. • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions. • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies. • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries. • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required. • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up. • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data. • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications: • 12+ years of clinical experience in university hospitals in Germany and Spain • International education: Ukraine – Germany – Spain • Member of the German Society of Surgeons (BDC) • Certified in radiological diagnostics and robotic surgery • Active participant in international medical conferences and research

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

CameraBook a video appointment
See all doctors

Stay informed and save on care

Get health tips, platform updates, and exclusive promos for subscribers.

Follow us on social media
FacebookInstagramTikTok